DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c06110 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2024. Written by Yu Fan and 7 co-authors. Institution: Department of Urology, Institute of Urology and Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Major MEDLINE topics: Reperfusion Injury, DNA, Interleukin-10, Acute Kidney Injury. Cited 17 times so far (Crossref); 41 references. Funded by: West China Hospital, Sichuan University, Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China.
Abstract (original language)
Renal ischemia-reperfusion injury (IRI) is a major contributing factor to the development of acute kidney injury (AKI) and has resulted in considerable morbidity and mortality. Persistent inflammatory responses and excessive reactive oxygen species (ROS) in the kidney following IRI can severely delay tissue repair, making it challenging to effectively promote IRI regeneration. Herein, we report an approach to enhance immunotherapy using interleukin-10 (IL-10) to promote IRI regeneration by loading IL-10 onto rectangular DNA origami nanostructures (rDON). rDON can significantly enhance the renal accumulation and retention time of IL-10, enabling it to effectively polarize type 1 macrophages into type 2 macrophages, thereby significantly reducing proinflammatory factors and increasing anti-inflammatory factors. In addition, DNA origami helps mitigate the harmful effects of ROS during renal IRI. The administration of IL-10-loaded DNA origami effectively improves kidney function, resulting in a notable reduction in blood urea nitrogen, serum uric acid, and serum creatinine levels. Our study demonstrates that the integration of anti-inflammatory cytokines within DNA origami holds promise as a strategic approach for cytokine immunotherapy in patients with AKI and other renal disorders.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, Institute of Urology and Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, China.
- NHC Key Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.
- Animal Experimental Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China.
ORCID profiles: Chengshi Wang, Gonggong Lu
Funding
- West China Hospital, Sichuan University
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
Cite
APA
Fan, Y., Wang, C., Dai, W., Zhou, Y., Lu, G., Li, W., Li, L., & Lin, T. (2024). DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c06110
Vancouver
Fan Y, Wang C, Dai W, Zhou Y, Lu G, Li W, et al. DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c06110
BibTeX
@article{Fan2024,
author = {Fan, Yu and Wang, Chengshi and Dai, Wenshu and Zhou, Yaojia and Lu, Gonggong and Li, Wei and Li, Ling and Lin, Tao},
title = {DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c06110}
}
EUVIMED